PMDA drug package insert
ワムナールDXII
PMDA OTC drug · ゼリア新薬工業（株） · package insert Jul 2, 2026
Key facts
| Brand names | ワムナールDXII |
|---|---|
| Companies | 製造販売元／池田薬品工業（株）,販売会社／ゼリア新薬工業（株） |
| Product type | OTC drug |
| OTC risk class | 第３類医薬品 |
| OTC dosage form | 塗布剤 |
| OTC effect category | 皮膚軟化薬（吸出しを含む） |
| Package insert date | Jul 2, 2026 |
| PMDA document key | 130036_J0701000342 |
| PMDA company code | 130036 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: